Yale University

Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?

TitleDrug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?
Publication TypeJournal Article
Year of Publication2008
AuthorsJustice, Amy C., David S. Zingmond, Kirsha S. Gordon, Shawn L. Fultz, Joseph L. Goulet, Joseph T. King, Dawn M. Bravata, Hernan Valdez, Michael Kraft, and Kristin M. Mattocks
Corporate AuthorsVeterans Aging Cohort Study Project Team
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume47
Issue9
Pagination1226-30
Date Published2008 Nov 1
ISSN1537-6591
KeywordsAdult, Age Factors, Anti-HIV Agents, California, Cohort Studies, Databases, Factual, Female, HIV Infections, Humans, Intracranial Hemorrhages, Male, Medicaid, Middle Aged, Pyridines, Pyrones, Risk Factors, United States, Veterans
AbstractThe US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.
DOI10.1086/592302
Alternate JournalClin. Infect. Dis.

External Links